Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Liabilities (2020 - 2022)

Atea Pharmaceuticals has reported Total Liabilities over the past 3 years, most recently at $23.4 million for Q3 2022.

  • Quarterly results put Total Liabilities at $23.4 million for Q3 2022, down 91.07% from a year ago — trailing twelve months through Sep 2022 was $23.4 million (down 91.07% YoY), and the annual figure for FY2021 was $62.8 million, down 80.11%.
  • Total Liabilities for Q3 2022 was $23.4 million at Atea Pharmaceuticals, down from $33.9 million in the prior quarter.
  • Over the last five years, Total Liabilities for AVIR hit a ceiling of $315.8 million in Q4 2020 and a floor of $10.9 million in Q3 2020.
  • Median Total Liabilities over the past 3 years was $62.8 million (2021), compared with a mean of $126.4 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 2310.34% in 2021 and later crashed 91.07% in 2022.
  • Atea Pharmaceuticals' Total Liabilities stood at $315.8 million in 2020, then tumbled by 80.11% to $62.8 million in 2021, then tumbled by 62.77% to $23.4 million in 2022.
  • The last three reported values for Total Liabilities were $23.4 million (Q3 2022), $33.9 million (Q2 2022), and $37.3 million (Q1 2022) per Business Quant data.